TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $86,323,000 | -58.0% | 4,727,415 | -58.1% | 1.98% | -62.9% |
Q4 2020 | $205,584,000 | +2.0% | 11,295,846 | 0.0% | 5.34% | -15.0% |
Q3 2020 | $201,518,000 | -2.2% | 11,295,846 | -1.7% | 6.28% | -4.6% |
Q2 2020 | $205,960,000 | +2.4% | 11,486,905 | -13.3% | 6.58% | -14.2% |
Q1 2020 | $201,055,000 | -23.1% | 13,244,711 | 0.0% | 7.67% | +36.0% |
Q4 2019 | $261,318,000 | +14.7% | 13,244,711 | 0.0% | 5.64% | +23.7% |
Q3 2019 | $227,809,000 | -2.8% | 13,244,711 | 0.0% | 4.56% | +14.5% |
Q2 2019 | $234,431,000 | -56.6% | 13,244,711 | -50.0% | 3.98% | -30.9% |
Q1 2019 | $539,590,000 | – | 26,489,422 | – | 5.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 7,931,116 | $140,381,000 | 32.92% |
Endurant Capital Management LP | 932,967 | $16,514,000 | 6.51% |
Glenview Capital Management | 26,430,828 | $467,826,000 | 4.24% |
Paulson & Co. | 13,244,711 | $234,431,000 | 3.98% |
Blackcrane Capital, LLC | 172,955 | $3,061,000 | 3.88% |
NINE MASTS CAPITAL Ltd | 1,474,286 | $26,146,000 | 3.74% |
Velanne Asset Management Ltd | 286,640 | $5,074,000 | 3.22% |
LMR Partners LLP | 4,563,591 | $80,884,000 | 2.95% |
SECTOR GAMMA AS | 796,299 | $14,094,000 | 2.26% |
MFN Partners Management, LP | 785,000 | $13,895,000 | 2.21% |